Russian scientists developed a new drug for cancer diagnostics and treatment
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin.Credit: Evgeny Pchelkin Russian ...
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin.Credit: Evgeny Pchelkin Russian ...
The study suggests an innovative, combined therapeutic approach that would include the administration of a NSD2 inhibitor drug together with ...
The 2018 annual meeting of the American Society of Hematology will include research from St. Jude Children's Research Hospital that ...
Research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical ...
Scientists from the RIKEN Cluster for Pioneering Research (CPR), Osaka University, and collaborators have developed a new rapid and inexpensive ...
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with ...
Study patients achieved goals with real-time access to dietitians and physiciansCredit: Houston Methodist Breast cancer survivors who used a smartphone ...
Forty percent of patients with diffuse large B-cell lymphoma had a complete response, most of which were durable In their ...
Updated data on JULIET trial presented at ASH Annual Meeting PHILADELPHIA - In an update to a global clinical trial ...
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.